Cargando…
Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial
BACKGROUND: Membranous nephropathy leads to end-stage renal disease in more than 20% of patients. Although immunosuppressive therapy benefits some patients, trial evidence for the subset of patients with declining renal function is not available. We aimed to assess whether immunosuppression preserve...
Autores principales: | Howman, Andrew, Chapman, Tracey L, Langdon, Maria M, Ferguson, Caroline, Adu, Dwomoa, Feehally, John, Gaskin, Gillian J, Jayne, David RW, O'Donoghue, Donal, Boulton-Jones, Michael, Mathieson, Peter W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lancet Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590447/ https://www.ncbi.nlm.nih.gov/pubmed/23312808 http://dx.doi.org/10.1016/S0140-6736(12)61566-9 |
Ejemplares similares
-
Current Nephrological Practice in the Investigation of Haematuria: Relationship to Incidence of IgA Nephropathy
por: Feehally, J., et al.
Publicado: (1989) -
Resurgence in home haemodialysis: perspectives from the UK
por: Mitra, Sandip, et al.
Publicado: (2011) -
Membranous Nephropathy
por: Mathieson, Peter
Publicado: (1997) -
SIADH and hyponatraemia: foreword
por: O’Donoghue, Donal, et al.
Publicado: (2009) -
An external validation of models to predict the onset of chronic kidney disease using population-based electronic health records from Salford, UK
por: Fraccaro, Paolo, et al.
Publicado: (2016)